HIV/AIDS

The Department of Medicine, Health and Society will host a panel discussion, “The Viral Underclass: Pandemic Inequality from HIV/AIDS to COVID-19,” on Tuesday, Nov. 15, from 1:15 to 2:30 p.m. in Furman Hall, Room 114. Read More

Vanderbilt University Orchestra will present “Artistic Memorials” on Saturday, Sept. 24, at 8 p.m. at the Martha Rivers Ingram Center for the Performing Arts. A panel discussion on the history of HIV/AIDS in Nashville will precede the concert at 6:30 p.m., and Music City PrEP will host a mobile clinic earlier in the day. Read More

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication. Read More

Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study. Read More

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease. Read More

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus. Read More

When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. Read More

When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care. Read More

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future. Read More

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce. Read More

Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states. Read More

Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health. Read More

Vanderbilt is one of 220 institutions whose scholars are invited to apply to a new competition. Read More

Third-year Vanderbilt University School of Medicine student Ishan Asokan has been selected as an inaugural member of the Elton John AIDS Foundation (EJAF) Fellowship for students addressing HIV/AIDS and health disparities. Read More

U.S. Ambassador-at-Large Deborah Birx, M.D., who oversees the President’s Emergency Program for AIDS Relief (PEPFAR), updated the Vanderbilt community on AIDS relief efforts during a visit last week. (Photo by John Russell) “Incredible progress” has been made in the fight against AIDS, but in some countries, especially… Read More

U.S. Ambassador-at-Large Deborah L. Birx will give an update on Friday, March 13, at Vanderbilt University School of Medicine on the President’s Emergency Plan for AIDS Relief (PEPFAR), a government-funded program that over the past 12 years has had a dramatic impact on the global HIV/AIDS epidemic. Read More

The World on Wednesday talk Nov. 12 will address “Reducing HIV Risk for Men Who Have Sex with Men in China.” Sten Vermund and Han-Zhu Qian of the Vanderbilt Institute for Global Health will speak. Read More

The Vanderbilt Comprehensive Care Clinic has received a nearly $54,000 grant for 2014-2015 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read More

The American Psychological Association has awarded Vanderbilt professor Velma McBride Murry a presidential citation for her distinguished research contributions and leadership as an advocate for children, youth and HIV risk prevention. Read More

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH). Read More